
Neuromodulation is the use of medications or technology to alter the activity of neurons with the goal of reducing symptoms, improving functioning, and improving quality of life. Over the past year, there have been some changes to the neuromodulation program at Weill Cornell Medicine and NewYork–Presbyterian. Dr. Dennis Popeo will discuss uses for electroconvulsive therapy beyond mood disorders. Dr. Roy Smetana will discuss ketamine treatment. Dr. Benjamin Zebley will discuss TMS. After the presentations, the three presenters will field questions from the audience about access to these services and other topics of interest regarding neuromodulation.